Donna F. Zarcone
Known title: DirectorCIK: 0001243083
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CDW Wins Dell Partner Award, Cited as Undervalued on AI Deal. CDW Corporation was named a Dell Technologies Partner for the fifth straight year, reinforcing its position in the IT distribution sector. Separately, a recent analysis suggests the stock may be undervalued following an AI services deal. The company's trailing P/E of 17.4 remains below the average analyst target of $158.67.
Transaction History
| CI | ▲ Buy | Grant | 782 | $0 | 4/22/2026 | View on chart |
| CDW | ▲ Buy | Grant | 79 | $0 | 3/10/2026 | View on chart |
| CDW | ▲ Buy | Grant | 1,609 | $0 | 3/5/2026 | View on chart |
| CDW | ▲ Buy | Grant | 59 | $9K | 12/10/2025 | View on chart |
| CDW | ▲ Buy | Grant | 51 | $0 | 9/10/2025 | View on chart |
| CDW | ▲ Buy | Grant | 49 | $0 | 6/10/2025 | View on chart |
| CI | ▲ Buy | Grant | 638 | $0 | 4/23/2025 | View on chart |
| CDW | ▲ Buy | Grant | 55 | $0 | 3/11/2025 | View on chart |
| CDW | ▲ Buy | Grant | 1,086 | $0 | 3/5/2025 | View on chart |
| CDW | ▲ Buy | Grant | 47 | $0 | 12/10/2024 | View on chart |
| CDW | ▲ Buy | Grant | 39 | $0 | 9/10/2024 | View on chart |
| CDW | ▲ Buy | Grant | 37 | $0 | 6/11/2024 | View on chart |
| CI | ▲ Buy | Grant | 539 | $0 | 4/24/2024 | View on chart |
| CDW | ▲ Buy | Grant | 38 | $0 | 3/12/2024 | View on chart |
| CDW | ▲ Buy | Grant | 718 | $0 | 3/6/2024 | View on chart |
| CDW | ▲ Buy | Grant | 44 | $0 | 12/12/2023 | View on chart |
| CDW | ▲ Buy | Grant | 44 | $0 | 9/12/2023 | View on chart |
| CDW | ▲ Buy | Grant | 52 | $0 | 6/13/2023 | View on chart |
| CI | ▼ Sell | Open Market | 757 | $192K | 5/1/2023 | View on chart |
| CI | ▲ Buy | Grant | 765 | $0 | 4/26/2023 | View on chart |
| CDW | ▲ Buy | Grant | 59 | $0 | 3/10/2023 | View on chart |
| CI | ▼ Sell | Open Market | 2,088 | $567K | 3/10/2023 | View on chart |
| CDW | ▲ Buy | Grant | 835 | $0 | 2/15/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 4,703 | $956K | 2/9/2023 | View on chart |
| CDW | ▲ Buy | Grant | 57 | $0 | 12/9/2022 | View on chart |
| CDW | ▲ Buy | Grant | 51 | $0 | 9/9/2022 | View on chart |
| CDW | ▲ Buy | Grant | 53 | $0 | 6/10/2022 | View on chart |
| CI | ▲ Buy | Grant | 757 | $0 | 4/27/2022 | View on chart |
| CDW | ▲ Buy | Grant | 66 | $0 | 3/10/2022 | View on chart |
| CI | ▲ Buy | Grant | 199 | $0 | 2/28/2022 | View on chart |
| CDW | ▲ Buy | Grant | 1,036 | $0 | 2/24/2022 | View on chart |
| CDW | ▲ Buy | Grant | 55 | $0 | 12/10/2021 | View on chart |
| CI | ▲ Buy | Grant | 247 | $0 | 11/30/2021 | View on chart |
| CDW | ▲ Buy | Grant | 43 | $0 | 9/10/2021 | View on chart |
| CI | ▲ Buy | Grant | 224 | $0 | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.